Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-011421
Filing Date
2013-02-25
Accepted
2013-02-25 20:15:12
Documents
1
Period of Report
2013-02-21

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c492442_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c492442_4x0.xml 4 3841
  Complete submission text file 0001209191-13-011421.txt   5469
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 EAGLEVIEW BLVD. EXTON PA 19341
Business Address
St.Clare Christine (Reporting) CIK: 0001570393 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31564 | Film No.: 13640751